<?xml version="1.0"?>

<document>
	<title>Interactions of Pseudomonas aeruginosa with immunoglobulins and
   complement in sputum.</title>

	<author>Hann-S.</author>
	<author>Holsclaw-D-S.</author>

	<source>Infect-Immun. 1976 Jul. 14(1). P 114-7.</source>

	<abstract>The interactions of Pseudomonas aeruginosa with humoral factors in
   the sputum of patients with cystic fibrosis were investigated by
   using an indirect immunofluorescent technique. Fluorescein-
   conjugated, monovalent antiserum specific to heavy chains of human
   immunoglobulin A (IgA), IgG, or IgM and to complement C3 were used.
   All strains of P. aeruginosa recovered from the sputum specimens of
   patients with cystic fibrosis were found to be coated with antibodies
   of IgA, IgG, and IgM classes and with C3. The specificity of the
   antibody coating was determined. The fluorescence was most intense
   with IgA and was followed in intensity by IgG, IgM, and C3. No
   difference was noted between rough and mucoid strains of P.
   aeruginosa. When the subcultured P. aeruginosa was incubated with the
   sputum eluates, a similar pattern of fluorescence was demonstrated,
   indicating that these humoral factors are present in the sputum and
   that the coating process can take place in the lower respiratory
   tract of the patients. By single radial immunodiffusion, significant
   quantities of the humoral factors in the sputum eluates were
   detected. These findings suggest that P. aeruginosa is opsonized in
   sputum of patients with cystic fibrosis.</abstract>

	<majorsubject>COMPLEMENT-3</majorsubject>
	<majorsubject>COMPLEMENT</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>IMMUNOGLOBULINS</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>
	<majorsubject>SPUTUM: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>ANTIGEN-ANTIBODY-REACTIONS</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>COMPLEMENT-3: an</minorsubject>
	<minorsubject>COMPLEMENT: an</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: mi</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IGA: an</minorsubject>
	<minorsubject>IGG: an</minorsubject>
	<minorsubject>IGM: an</minorsubject>
	<minorsubject>IMMUNOGLOBULINS: an</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>SPUTUM: mi</minorsubject>

	<reference>001   BIGGAR WD             PROC NAT ACAD SCI USA           68  1716 971</reference>
	<reference>002   BOXERBAUM B           AM REV RESPIR DIS              108   777 973</reference>
	<reference>003   BOYDEN SV             IN: WOLSTENHOLME GEW                 190 976</reference>
	<reference>004   GOTZE O               J EXP MED                      134   90S 971</reference>
	<reference>005   GREEN GM              N ENGL J MED                   276   421 967</reference>
	<reference>006   GREEN GM              J CLIN INVEST                   43   769 964</reference>
	<reference>007   GUGLER EC             J PEDIATR                       73   548 968</reference>
	<reference>008   HUANG NN              J PEDIATR                       59   512 961</reference>
	<reference>009   IACOCCA VF            AM J DIS CHILD                 106   315 963</reference>
	<reference>010   ISHIZAKA T            J IMMUNOL                       97   716 966</reference>
	<reference>011   JOHNSTON RB JR        J EXP MED                      129  1275 969</reference>
	<reference>012   MARCER V              RIV CLIN PEDIATR                83   135 970</reference>
	<reference>013   OREN R                J CELL BIOL                     17   486 963</reference>
	<reference>014   REYNOLDS HY           GAP CONF REP PSEUDOMON IN CF           7 974</reference>
	<reference>015   SMITH MR              PROC NAT ACAD SCI USA           63  1151 969</reference>
	<reference>016   SOUTH MA              J PEDIATR                       71   645 967</reference>
	<reference>017   THOMAS V              N ENGL J MED                   290   588 974</reference>
	<reference>018   WILLIAMS RC JR        IMMUNOLOGY                      17   249 969</reference>
	<reference>019   WINKELSTEIN JA        J PEDIATR                       82   747 973</reference>
	<reference>020   YOUNG LS              J INFECT DIS                   126   257 972</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>2   SORENSEN RU           INFECT IMMUN                    18   735 977</citation>
	<citation>3   SORENSEN RU           J PEDIATR                       93   201 978</citation>
	<citation>4   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979</citation>
	<citation>5   SHAW JO               LAB INVEST                      42   547 980</citation>
	<citation>6   HOMMA JY              JAP J EXP MED                   50   149 980</citation>
	<citation>7   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981</citation>
	<citation>8   KOLB WP               AM REV RESPIR DIS              123   226 981</citation>
	<citation>9   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>10   OLIVER AM             J CLIN LAB IMMUNOL              10   221 983</citation>
	<citation>11   SCHILLER NL           PEDIATR RES                     17   747 983</citation>
	<citation>12   SORENSEN RU           EUR J RESPIR DIS                64   524 983</citation>
	<citation>13   PIER GB               J INFECT DIS                   150   223 984</citation>
	<citation>14   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985</citation>
	<citation>15   PIEDRA P              J PEDIATR                      108   817 986</citation>

</document>
